Rhythm Pharmaceuticals, Inc. (RYTM) on GreekSoup https://greeksoup.ai/stocks/us/rytm/ Every dated entry in the public record on Rhythm Pharmaceuticals, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Rhythm Pharmaceuticals, Inc.: short interest 11,003,490 shares at the 15 October 2026 settlement, 13.48 days to coverhttps://greeksoup.ai/stocks/us/rytm/short-interest/us:RYTM:short-interest:2026-10-15:dd9d51391eThu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Schedule 13G filed by JPMORGAN CHASE & CO., 5.1% of the classhttps://greeksoup.ai/stocks/us/rytm/holders/us:RYTM:schedule-13:2026-10-13:1b6a35dd79Tue, 13 Oct 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: short interest 10,767,698 shares at the 30 September 2026 settlement, 14.14 days to coverhttps://greeksoup.ai/stocks/us/rytm/short-interest/us:RYTM:short-interest:2026-09-30:1b4cdd0882Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: short interest 10,287,811 shares at the 15 September 2026 settlement, 20.06 days to coverhttps://greeksoup.ai/stocks/us/rytm/short-interest/us:RYTM:short-interest:2026-09-15:b196c02541Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Form 144, David Meeker plans to sell 50,000 shares worth $5.2 million around 14 September 2026https://greeksoup.ai/stocks/us/rytm/planned-sales/us:RYTM:planned-sale:2026-09-14:08703a29e8Mon, 14 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Meeker David P (President and CEO) sold 6,439 shares (under a trading plan set in advance) at $101.75 on 14 September 2026, $655,145https://greeksoup.ai/stocks/us/rytm/insiders/us:RYTM:insider:2026-09-14:e68b6743dfMon, 14 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Meeker David P (President and CEO) sold 30,746 shares (under a trading plan set in advance) at $102.35 on 14 September 2026, $3.1 millionhttps://greeksoup.ai/stocks/us/rytm/insiders/us:RYTM:insider:2026-09-14:65fc5bd58eMon, 14 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Meeker David P (President and CEO) sold 8,698 shares (under a trading plan set in advance) at $103.43 on 14 September 2026, $899,634https://greeksoup.ai/stocks/us/rytm/insiders/us:RYTM:insider:2026-09-14:ba50101376Mon, 14 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Meeker David P (President and CEO) sold 1,817 shares (under a trading plan set in advance) at $104.55 on 14 September 2026, $189,965https://greeksoup.ai/stocks/us/rytm/insiders/us:RYTM:insider:2026-09-14:312b63a555Mon, 14 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Meeker David P (President and CEO) sold 2,300 shares (under a trading plan set in advance) at $105.19 on 14 September 2026, $241,937https://greeksoup.ai/stocks/us/rytm/insiders/us:RYTM:insider:2026-09-14:cb5d7e77f0Mon, 14 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Smith Hunter C (Chief Financial Officer) sold 23,072 shares (under a trading plan set in advance) at $104.59 on 31 August 2026, $2.4 millionhttps://greeksoup.ai/stocks/us/rytm/insiders/us:RYTM:insider:2026-09-01:c6d34971b8Tue, 01 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Smith Hunter C (Chief Financial Officer) sold 11,514 shares (under a trading plan set in advance) at $105.37 on 31 August 2026, $1.2 millionhttps://greeksoup.ai/stocks/us/rytm/insiders/us:RYTM:insider:2026-09-01:5289703accTue, 01 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Smith Hunter C (Chief Financial Officer) sold 28,188 shares (under a trading plan set in advance) at $106.20 on 31 August 2026, $3.0 millionhttps://greeksoup.ai/stocks/us/rytm/insiders/us:RYTM:insider:2026-09-01:621423a433Tue, 01 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Form 144, HUNTER SMITH plans to sell 62,774 shares worth $6.7 million around 31 August 2026https://greeksoup.ai/stocks/us/rytm/planned-sales/us:RYTM:planned-sale:2026-08-31:166d8d9b83Mon, 31 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: short interest 10,303,031 shares at the 31 August 2026 settlement, 21.89 days to coverhttps://greeksoup.ai/stocks/us/rytm/short-interest/us:RYTM:short-interest:2026-08-31:34efe07c7dMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Shulman Joseph (Chief Technical Officer) sold 5,079 shares (under a trading plan set in advance) at $119.75 on 13 August 2026, $608,210https://greeksoup.ai/stocks/us/rytm/insiders/us:RYTM:insider:2026-08-17:4e0c74b24aMon, 17 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Garfield Alastair (Chief Scientific Officer) sold 2,007 shares (under a trading plan set in advance) at $116.11 on 13 August 2026, $233,031https://greeksoup.ai/stocks/us/rytm/insiders/us:RYTM:insider:2026-08-17:a520da5a1cMon, 17 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Garfield Alastair (Chief Scientific Officer) sold 1,556 shares (under a trading plan set in advance) at $117.08 on 13 August 2026, $182,170https://greeksoup.ai/stocks/us/rytm/insiders/us:RYTM:insider:2026-08-17:2d8d3171ecMon, 17 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Garfield Alastair (Chief Scientific Officer) sold 3,400 shares (under a trading plan set in advance) at $118.28 on 13 August 2026, $402,167https://greeksoup.ai/stocks/us/rytm/insiders/us:RYTM:insider:2026-08-17:d9d98f66a6Mon, 17 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Garfield Alastair (Chief Scientific Officer) sold 800 shares (under a trading plan set in advance) at $119.17 on 13 August 2026, $95,335https://greeksoup.ai/stocks/us/rytm/insiders/us:RYTM:insider:2026-08-17:380d2b9c5cMon, 17 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Lee Jennifer Kayden (EVP, Head of North America) sold 75,834 shares (under a trading plan set in advance) at $117.38 on 13 August 2026, $8.9 millionhttps://greeksoup.ai/stocks/us/rytm/insiders/us:RYTM:insider:2026-08-14:986f33e6daFri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Mazabraud Yann (EVP, Head of International) sold 2,300 shares (under a trading plan set in advance) at $111.80 on 12 August 2026, $257,138https://greeksoup.ai/stocks/us/rytm/insiders/us:RYTM:insider:2026-08-14:56ca73d84fFri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Mazabraud Yann (EVP, Head of International) sold 1,000 shares (under a trading plan set in advance) at $112.86 on 12 August 2026, $112,856https://greeksoup.ai/stocks/us/rytm/insiders/us:RYTM:insider:2026-08-14:a821089f9dFri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Mazabraud Yann (EVP, Head of International) sold 3,605 shares (under a trading plan set in advance) at $114.70 on 12 August 2026, $413,477https://greeksoup.ai/stocks/us/rytm/insiders/us:RYTM:insider:2026-08-14:6c9f93f3b5Fri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Mazabraud Yann (EVP, Head of International) sold 14,568 shares (under a trading plan set in advance) at $115.43 on 12 August 2026, $1.7 millionhttps://greeksoup.ai/stocks/us/rytm/insiders/us:RYTM:insider:2026-08-14:3a26033ea4Fri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Mazabraud Yann (EVP, Head of International) sold 18,208 shares (under a trading plan set in advance) at $116.49 on 12 August 2026, $2.1 millionhttps://greeksoup.ai/stocks/us/rytm/insiders/us:RYTM:insider:2026-08-14:1999f1f99bFri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Mazabraud Yann (EVP, Head of International) sold 17,319 shares (under a trading plan set in advance) at $117.47 on 12 August 2026, $2.0 millionhttps://greeksoup.ai/stocks/us/rytm/insiders/us:RYTM:insider:2026-08-14:9bfe26a4d9Fri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: short interest 10,154,327 shares at the 14 August 2026 settlement, 12.24 days to coverhttps://greeksoup.ai/stocks/us/rytm/short-interest/us:RYTM:short-interest:2026-08-14:421dffc641Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Form 144, JOSEPH J SHULMAN plans to sell 5,079 shares worth $597,290 around 13 August 2026https://greeksoup.ai/stocks/us/rytm/planned-sales/us:RYTM:planned-sale:2026-08-13:14b065bf40Thu, 13 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Form 144, ALASTAIR GARFIELD plans to sell 7,763 shares worth $912,929 around 13 August 2026https://greeksoup.ai/stocks/us/rytm/planned-sales/us:RYTM:planned-sale:2026-08-13:afab3ebaeaThu, 13 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Form 144, Jennifer Kayden Lee plans to sell 75,834 shares worth $8.9 million around 13 August 2026https://greeksoup.ai/stocks/us/rytm/planned-sales/us:RYTM:planned-sale:2026-08-13:bc47178990Thu, 13 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Form 144, YANN MAZABRAUD plans to sell 57,000 shares worth $6.4 million around 12 August 2026https://greeksoup.ai/stocks/us/rytm/planned-sales/us:RYTM:planned-sale:2026-08-12:f0b0555c21Wed, 12 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Form 144, PAMELA CRAMER plans to sell 11,406 shares worth $1.3 million around 11 August 2026https://greeksoup.ai/stocks/us/rytm/planned-sales/us:RYTM:planned-sale:2026-08-11:6b354f8654Tue, 11 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: Form 144, PAMELA CRAMER plans to sell 3,520 shares worth $407,018 around 10 August 2026https://greeksoup.ai/stocks/us/rytm/planned-sales/us:RYTM:planned-sale:2026-08-10:8823c43addMon, 10 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc. Q2 FY2026 results: revenue $71 million, net income -$49 millionhttps://greeksoup.ai/stocks/us/rytm/results/fy2026-q2/us:RYTM:result:2026-08-04:bf32062353Tue, 04 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/rytm/filings/us:RYTM:filing:2026-08-04:063024feb7Tue, 04 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc. filed 8-K: results of operations, regulation fd disclosure, other eventshttps://greeksoup.ai/stocks/us/rytm/filings/us:RYTM:filing:2026-08-04:a32f81822cTue, 04 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Rhythm Pharmaceuticals, Inc.: short interest 9,440,417 shares at the 31 July 2026 settlement, 16.17 days to coverhttps://greeksoup.ai/stocks/us/rytm/short-interest/us:RYTM:short-interest:2026-07-31:f036ae1c9dFri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>